This test is most useful if any of these apply to you.
Your urine carries traces of how your body processes protein, and one of those traces is phenyllactic acid. It rises when your usual route for breaking down the amino acid phenylalanine gets diverted into a backup pathway, or when gut bacteria step in and produce it themselves.
This is a research-grade marker, not a routine test. It sits at the intersection of liver metabolism, kidney filtration, gut microbial activity, and recent diet. That makes it interesting for people who want a deeper view of what's happening inside them, while also requiring careful interpretation.
Phenyllactic acid (PLA, also written as 3-phenyllactic acid) is what's called an organic acid, meaning a small molecule with an acidic chemical group. It's produced when phenylalanine, an amino acid you get from protein in food, gets converted into a compound called phenylpyruvate and then reduced into phenyllactic acid. This is a side route, used more heavily when the main pathway that breaks phenylalanine down to tyrosine isn't running smoothly.
Certain gut bacteria, especially lactic acid bacteria and some Bifidobacterium species, also make phenyllactic acid directly from phenylalanine. In breastfed infants, Bifidobacterium species in the gut convert phenylalanine into phenyllactic acid using a dedicated enzyme called aromatic lactate dehydrogenase. The acid then enters circulation and is filtered out by your kidneys, which is why it shows up in urine.
Because the molecule is gut-derived and renally excreted, a urine reading reflects a mix of three things: how much phenylalanine your body is processing through the backup route, what your gut microbes are producing, and how well your kidneys are clearing the result. Note that the naturally occurring form in mammalian metabolism is predominantly the L-enantiomer, while microbial production can yield a mix of both forms.
The strongest, oldest evidence for phenyllactic acid in urine comes from phenylketonuria (PKU), an inherited condition where the enzyme that converts phenylalanine to tyrosine doesn't work properly. With that main pathway blocked, phenylalanine piles up and gets shunted into the backup route, producing large amounts of phenyllactic acid and related acids.
In hyperphenylalaninemic and PKU patients, urinary and serum phenyllactic acid rise as serum phenylalanine rises, and 24-hour urinary excretion depends directly on the blood level. After a phenylalanine load, the pattern of urinary aromatic acids reliably distinguishes PKU from healthy infants and from milder forms of high phenylalanine. Reference ranges for these acids in PKU were defined in a study of 61 children and juveniles.
Phenyllactic acid also appears alongside other aromatic acids in rarer enzyme deficiencies and in some liver conditions, where impaired aromatic amino acid handling forces metabolism into alternate channels.
What you ate recently can move this number, and that's actually useful information. In a controlled crossover study in healthy adults, urinary 3-phenyllactic acid specifically tracked cheese intake. In a separate study comparing yogurt to milk in healthy men, 3-phenyllactic acid was higher after yogurt than milk in both blood and urine.
The reason is microbial. Lactic acid bacteria used to ferment dairy, sourdough, and other foods produce phenyllactic acid directly. When you eat those foods, you're partly absorbing the acid they made. So a high reading after a yogurt-and-cheese-heavy week isn't a disease signal, it's a diet signal. Phenyllactic acid also has natural antimicrobial properties, which is one of the reasons it has drawn interest in food science.
Phenyllactic acid is one of many gut-derived metabolites that the body filters through the kidneys. In people with diabetic kidney disease, serum L-(-)-3-phenyllactic acid was among the metabolites positively correlated with progression of the disease, reflecting both microbial production and changes in clearance. This was observed in a study of 41 predialysis patients, and the relationship was with progression markers rather than a clean inverse relationship with filtration rate.
In a much larger study of 4,833 adults, gut microbe-derived products from aromatic amino acids (the broader family of metabolites that phenyllactic acid belongs to) were independently linked to higher risk of major cardiac events and shorter survival. The specific metabolites most strongly tied to those outcomes were phenylacetylglutamine, p-cresol sulfate, and indole derivatives, not urinary phenyllactic acid in isolation, but the work places this pathway on the cardiovascular research map.
Higher isn't always worse and lower isn't always better with this marker. In severe heart disease, a structurally related but distinct metabolite called 3,4-dihydroxyphenyllactic acid (a version of phenyllactic acid with two extra hydroxyl groups) was found in patient urine but absent in healthy controls, and it dropped as patients recovered, suggesting it functions partly as a stress-response metabolite. In multiple sclerosis, a single study of 85 patients reported that lower serum phenyllactic acid was associated with a more benign disease course, while higher levels tracked with a more inflammatory immune profile. That finding is preliminary and has not been replicated in larger cohorts.
The way to make sense of this: phenyllactic acid is a phenotype indicator, not a simple good-or-bad number. It reflects which biological process is dominant at the time of measurement, whether that's diet, gut microbial activity, an inherited metabolic block, or kidney filtration. Interpretation depends entirely on context.
A single urine reading can be shifted by several things that have nothing to do with underlying disease:
Because of this mix of influences, one isolated reading rarely tells a clean story. Trends over time, with consistent collection conditions, are far more useful.
This marker is best understood as a trajectory rather than a snapshot. The same person can show different values on different days depending on diet, hydration, gut activity, and timing of collection. A single reading at one point in time, on its own, is hard to interpret.
No clinical guidelines exist for monitoring urinary phenyllactic acid in healthy adults, so any retest schedule is practical rather than evidence-based. One reasonable approach: get a baseline reading, then retest after a few months if you're making meaningful diet or supplement changes, and at a roughly yearly cadence if you're using it as part of a broader metabolic screening program. Pay attention to direction and magnitude of change rather than to crossing any particular threshold. Standardized clinical cutpoints for urinary phenyllactic acid in healthy adults do not yet exist, which is exactly why your own trend matters more than a population reference.
If your urinary phenyllactic acid comes back unusually high or unusually low, the next step is not to act on the number alone. It's to put it in context with other tests and your recent history.
A markedly elevated reading, particularly one that persists across multiple samples, is worth investigating alongside a broader urine organic acid panel, blood amino acids, and kidney function tests. In adults with no known metabolic disorder, the more likely explanations are diet and gut microbial activity, not an inherited enzyme problem. If results stay unusual after eliminating fermented foods for a couple of weeks and retesting, a consultation with a metabolic specialist or a clinician familiar with organic acid testing can help interpret the pattern.
Combinations of findings carry more weight than any single value. High phenyllactic acid alongside other phenylalanine-pathway metabolites points one direction. High phenyllactic acid with normal phenylalanine but unusual microbial markers points another. The decision pathway is about pattern recognition, not threshold crossing.
Evidence-backed interventions that affect your Phenyllactic Acid level
Phenyllactic Acid is best interpreted alongside these tests.
Phenyllactic Acid is included in these pre-built panels.